Anlon Healthcare IPO Description – Anlon Healthcare is a chemical manufacturing company specializing in high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its product portfolio spans 65 commercialized products, 28 at the pilot stage, and 49 at the laboratory scale. The company is one of the few Indian manufacturers of loxoprofen sodium dihydrate, an API widely used in treating pain and inflammation.
Anlon manufactures APIs in compliance with global pharmacopeia standards (IP, BP, EP, JP, USP) and has secured Drug Master File (DMF) approvals from ANVISA (Brazil), NMPA (China), and PMDA (Japan), with 21 DMFs filed across the EU, Russia, South Korea, Iran, Jordan, Pakistan, and others. In Fiscal 2025, Anlon manufactured 338 MT of APIs and intermediates, serving 38 customers, respectively. Revenues from exports were INR 3.90 crore, contributing 3.24 of total revenues, while domestic operations generated INR 116.39 crore in the same period.
Operations are supported by a 5,059 sq. mtrs. manufacturing facility in Rajkot, Gujarat, with a 400 MTPA capacity, two production blocks, four in-house laboratories, and advanced reactors up to 4 KL. The company employs 105 full-time staff as of 30 June 2025, and supplies products to customers across 15 countries, including Germany, Italy, Japan, Brazil, and the UK.
Promoters of Anlon Healthcare – Punitkumar R. Rasadia, Meet Atulkumar Vachhani, and Mamata Punitkumar Rasadia
Table of Contents
Anlon Healthcare IPO Details
| Anlon Healthcare IPO Dates | 26 – 29 August 2025 |
| Anlon Healthcare IPO Price | INR 86 – 91 per share |
| Fresh issue | 1,33,00,000 shares (INR 114.38 – 121.03 crore) |
| Offer For Sale | NIL |
| Total IPO size | 1,33,00,000 shares (INR 114.38 – 121.03 crore) |
| Minimum bid (lot size) | 164 shares (INR 14,924) |
| Face Value | INR 10 per share |
| Retail Allocation | 10% |
| Listing On | NSE, BSE |
Anlon Healthcare Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 112.88 | 66.58 | 120.29 |
| Expenses | 106.13 | 56.94 | 93.57 |
| Net income | 5.82 | 9.66 | 20.52 |
| Margin (%) | 5.16 | 14.51 | 17.06 |
Anlon Healthcare Offer News
- Anlon Healthcare RHP
- Anlon Healthcare DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Anlon Healthcare Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2025 (Post-Issue)* | |
| EPS | 4.85 | 6.68 | 6.38 | 3.86 |
| PE Ratio | – | – | 13.48 – 14.26 | 22.28 – 23.57 |
| FY 2023 | FY 2024 | FY 2025 | |
| RONW (%) | 78.92 | 45.92 | 25.51 |
| NAV | 6.15 | 13.14 | 20.18 |
| ROCE (%) | 17.16 | 16.29 | 21.93 |
| EBITDA (%) | 18.51 | 23.35 | 26.88 |
| Debt/Equity | 9.00 | 3.55 | 0.73 |
Anlon Healthcare IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 2 September 2025 | 3 | – | 200 |
| 1 September 2025 | 3 | – | 200 |
| 30 August 2025 | 3 | – | 200 |
| 29 August 2025 | 5 | – | 500 |
| 28 August 2025 | 5 | – | 500 |
| 27 August 2025 | 5 | – | 500 |
| 26 August 2025 | 7 | – | 700 |
Anlon Healthcare IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Funding capital expenditure requirements for expansion of the manufacturing facility – INR 30.72 crore
- Full or part repayment and/or prepayment of certain outstanding secured borrowings (term loan) availed by the company – INR 5 crore
- Funding the working capital requirements of the company – INR 43.15 crore
- General corporate purposes
Anlon Healthcare IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 99,75,000 | 19,95,000 | 13,30,000 | 1,33,00,000 |
| 29 Aug 2025 | 1.07 | 10.61 | 47.29 | 7.12 |
| 28 Aug 2025 | 1.01 | 2.09 | 22.32 | 3.30 |
| 26 Aug 2025 | 0.91 | 0.71 | 8.99 | 1.69 |
Anlon Healthcare – Comparison With Listed Peer
| Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
| Anlon Healthcare | 14.26 | 6.38 | 25.51 | 20.18 | 120.29 |
| Kronox Lab Sciences | 26.18 | 6.91 | 28.26 | 24.28 | 100.19 |
| Acutaas Chemicals | 58.47 | 19.81 | 12.15 | 161.24 | 1,006.88 |
Anlon Healthcare IPO Allotment Status
Anlon Healthcare IPO allotment status is now available on the KFin Tech website. Click on this link to get the allotment status.
Anlon Healthcare IPO Dates & Listing Performance
| IPO Opening Date | 26 August 2025 |
| IPO Closing Date | 29 August 2025 |
| Finalization of Basis of Allotment | 1 September 2025 |
| Initiation of refunds | 2 September 2025 |
| Transfer of shares to demat accounts | 2 September 2025 |
| Anlon Healthcare IPO Listing Date | 3 September 2025 |
| Opening Price on NSE | INR 92 per share (up 1.10%) |
| Closing Price on NSE | INR 91.73 per share (up 0.80%) |
Anlon Healthcare IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth – Subscribe
Capital Market – Neutral
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital – Avoid
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking – Neutral
KR Choksey –
LKP Research –
Marwadi Financial – Avoid
Motilal Oswal –
Mehta Equities –
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities – Not rated
SBI Securities –
SMC Global – 2/5
SMIFS –
Systematix Research –
Swastika Investmart –
Ventura Securities – Subscribe
Anlon Healthcare Offer Lead Manager
INTERACTIVE FINANCIAL SERVICES LIMITED
Office No. 508, Fifth Floor, Priviera,
Nehru Nagar, Ahmedabad – 380 015, Gujarat
Phone: +91 079-4908 8019 / +91 98980 55647
Email: [email protected]
Website: www.ifinservices.in
Anlon Healthcare Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 6716 2222/18003094001
E-mail: [email protected]
Website: www.kfintech.com
Anlon Healthcare Contact Details
ANLON HEALTHCARE LIMITED
101/102, Silvercoin Complex, Opp.Crystal Mall,
Kalawad Road, Rajkot – 360 005, Gujarat, India
Phone: +91 281 256 2538/39
Email: [email protected]
Website: www.anlon.in
Anlon Healthcare IPO FAQs
How many shares in the Anlon Healthcare IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 75%, NII – 15%, and Retail – 10%.
How to apply for the Anlon Healthcare Public Offer?
The best way to apply for the Anlon Healthcare public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is the Anlon Healthcare IPO GMP today?
Anlon Healthcare IPO GMP today is INR 3 per share.
What is the Anlon Healthcare kostak rate today?
Anlon Healthcare kostak rate today is INR NA per application.
What is Anlon Healthcare Subject to Sauda rate today?
Anlon Healthcare Subject to Sauda rate today is INR 200 per application.